Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Listen Now

Topics Covered

• Review of Chronic Lymphocytic Leukemia (CLL)
• Significant Role of Testing in Informing Your Treatment Choices
• First Line Treatment Options
• Treatment for Relapsed & Refractory CLL
• Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
• Current Perspectives on New & Emerging Treatment of CLL
• Updates on Clinical Trials & Their Significance for CLL
• Key Questions to Ask & Re-Ask Your Health Care Team
• Practical and Psychosocial Support to Cope with CLL
• Questions for Our Panel of Experts

Our Panel of Experts

Jennifer R. Brown, MD, PhD

Professor of Medicine, Harvard Medical School, Director, CLL Center, Dana-Farber Cancer Institute

Mazyar Shadman, MD, MPH

Physician, Seattle Cancer Care Alliance, Assistant Professor, Division of Medical Oncology, University of Washington School of Medicine, Assistant Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center

Patricia Koffman

Co-Founder and Executive Director, CLL Society, Inc.

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on April 30, 2020.